Observational studyScientific reports2025

Body composition changes and clinical outcomes in pediatric cystic fibrosis during 24 months of lumacaftor ivacaftor therapy based on real-world data.

Marcell Imrei et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.